Vol 29, No 5 (2024)
Clinical vignette
Published online: 2024-10-16
Local chemotherapy with conjunctival bevacizumab injections in case of lymphoma tumor
DOI: 10.5603/rpor.102880
Rep Pract Oncol Radiother 2024;29(5):661-665.
Abstract
Not required for Clinical Vignette.
Keywords: lymphomaAvastin–Bevacizumab injectionslocal chemotherapy
References
- Ferreri A, Sassone M, Miserocchi E, et al. Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum. Blood Adv. 2020; 4(6): 1013–1019.
- Tanenbaum RE, Galor A, Dubovy SR, et al. Classification, diagnosis, and management of conjunctival lymphoma. Eye Vis (Lond). 2019; 6: 22.
- Zagórski Z, Nauman GO, Watson P. Choroby rogówki, twardówki i powierzchni oka. Wydawnictwo Czelej, Lublin 2008: 306–307.
- Seca M, Borges P, Reimão P, et al. Conjunctival lymphangioma: a case report and brief review of the literature. Case Rep Ophthalmol Med. 2012; 2012: 836573.
- Patnam M, Dommaraju SR, Masood F, et al. Lymphangiogenesis Guidance Mechanisms and Therapeutic Implications in Pathological States of the Cornea. Cells. 2023; 12(2).
- Klavdianou O, Kondylis G, Georgopoulos V, et al. Bilateral benign reactive lymphoid hyperplasia of the conjunctiva: a case treated with oral doxycycline and review of the literature. Eye Vis (Lond). 2019; 6: 26.
- Ferreri AJM, Assanelli A, Crocchiolo R, et al. Therapeutic management of ocular adnexal MALT lymphoma. Expert Opin Pharmacother. 2007; 8(8): 1073–1083.
- Ferreri AJM, Govi S, Pasini E, et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012; 30(24): 2988–2994.
- Bansal S, Das S. Intralesional bleomycin: A treatment modality for conjunctival lymphangioma. Oman J Ophthalmol. 2020; 13(1): 43–45.
- Oh DH, Chun YS, Kim JC. A case of ocular benign lymphoid hyperplasia treated with bevacizumab injection. Korean J Ophthalmol. 2011; 25(1): 57–59.
- Garcia J, Hurwitz HI, Sandler AB, et al. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook. Cancer Treat Rev. 2020; 86: 102017.
- Patnam M, Dommaraju SR, Masood F, et al. Lymphangiogenesis Guidance Mechanisms and Therapeutic Implications in Pathological States of the Cornea. Cells. 2023; 12(2).